MediXall Group, Inc. (MDXL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MediXall Group, Inc. (MDXL) trades at $0.01 with AI Score 60/100 (Grade B+). MediXall Group, Inc. operates a healthcare marketplace platform aimed at enhancing consumer engagement in healthcare decisions. Market cap: $1.15M, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for MDXL: MDXL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDXL against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
MDXL: the 4 perspectives are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →MediXall Group, Inc. (MDXL) Healthcare & Pipeline Overview
MediXall Group, Inc. is a healthcare marketplace innovator, offering the Health Karma platform to facilitate consumer engagement in healthcare decisions, thereby enhancing relationships with trusted healthcare providers in the U.S.
What Is the Investment Thesis for MDXL?
MediXall Group, Inc. is poised for growth as the demand for healthcare information services increases. The company’s Health Karma platform represents a significant value driver, with the potential to capture a larger share of the healthcare marketplace. The ongoing digital transformation in healthcare, coupled with rising consumer expectations for transparency and accessibility, presents a favorable environment for MediXall. Additionally, the company’s focus on partnerships with employer groups and third-party administrators could lead to increased user adoption and revenue streams. However, the company faces challenges, including a high profit margin deficit of -1474.8%, which underscores the need for operational improvements and strategic investments to enhance profitability over the next few years.
Based on FMP financials and quantitative analysis
MDXL Key Highlights
- Market Cap: $0.00B, indicating a nascent stage in market presence.
- Profit Margin: -1474.8%, highlighting significant operational challenges.
- Gross Margin: 23.6%, reflecting the cost structure of service delivery.
- Beta: 274.99, indicating high volatility in stock performance.
- Dividend Yield: None, as the company does not currently distribute dividends.
Who Are MDXL's Competitors?
MDXL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMWL American Well Corporation (AMWL) | $9.28 | +0.27% | $154.97M | — |
| TDOC Teladoc Health, Inc. | $9.29 | +1.03% | $1.68B | — |
| CLOV Clover Health Investments, Corp. | $5.04 | -4.18% | $2.61B | 36 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| VPAHF Volpara Health Technologies Limited | $0.74 | +36.63% | $188.24M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDXL's Key Strengths?
- Innovative healthcare marketplace platform.
- Focus on consumer empowerment and decision-making.
- Established relationships with employer groups and administrators.
What Are MDXL's Weaknesses?
- High negative profit margin indicating operational inefficiencies.
- Limited employee base may restrict growth potential.
- Dependence on partnerships for user acquisition.
What Could Drive MDXL Stock Higher?
- Potential integration of telehealth services into the Health Karma platform.
- Expansion of partnerships with employer groups to enhance user acquisition.
- Development of new features to improve user engagement and experience.
What Are the Key Risks for MDXL?
- Regulatory changes impacting the healthcare marketplace.
- High operational costs leading to negative profit margins.
- Competition from established healthcare information service providers.
What Are the Growth Opportunities for MDXL?
- Growth opportunity 1: The increasing adoption of telehealth services is a significant growth driver for MediXall. The telehealth market is expected to reach $459.8 billion by 2030, growing at a CAGR of 23.4%. MediXall can leverage this trend by integrating telehealth services into its platform, enhancing user engagement and expanding its service offerings.
- Growth opportunity 2: Expanding partnerships with employer groups can drive user acquisition for MediXall. As employers increasingly seek to provide comprehensive health benefits, MediXall's platform can serve as a valuable resource for employers looking to enhance employee wellness. This market is projected to grow as companies prioritize health benefits, potentially increasing MediXall's user base significantly.
- Growth opportunity 3: The rise of consumer-driven healthcare is reshaping the industry, with patients seeking more transparency and control over their healthcare decisions. MediXall's platform aligns with this trend, providing tools for users to compare services and prices. As this market continues to evolve, MediXall can capture a larger share by enhancing its platform's capabilities.
- Growth opportunity 4: The integration of AI and machine learning into healthcare services presents an opportunity for MediXall to enhance its platform. By utilizing these technologies, the company can offer personalized healthcare recommendations and improve user experience. The AI healthcare market is expected to reach $188 billion by 2030, providing a significant opportunity for growth.
- Growth opportunity 5: Geographic expansion into underserved markets can provide MediXall with new revenue streams. Many regions in the U.S. still lack comprehensive healthcare marketplace solutions. By targeting these areas, MediXall can establish a foothold and cater to a growing population seeking accessible healthcare services.
What Opportunities Does MDXL Have?
- Growing telehealth market presents integration opportunities.
- Increasing demand for consumer-driven healthcare solutions.
- Potential for geographic expansion into underserved markets.
What Threats Does MDXL Face?
- Intense competition from established healthcare information service providers.
- Regulatory changes impacting healthcare delivery.
- Economic downturns affecting consumer spending on healthcare.
What Are MDXL's Competitive Advantages?
- Unique marketplace model that combines various healthcare services in one platform.
- Strong focus on consumer empowerment and transparency in healthcare decisions.
- Partnerships with employer groups and third-party administrators enhance market reach.
- Innovative technology integration allows for personalized user experiences.
- Small team enables agile decision-making and rapid adaptation to market changes.
What Does MDXL Do?
Founded in 1998 and headquartered in Fort Lauderdale, Florida, MediXall Group, Inc. is a pioneering company in the healthcare information services sector. The company was established to address the growing need for a more transparent and accessible healthcare marketplace. MediXall operates the Health Karma platform, which serves as a comprehensive marketplace for medical and wellness services, enabling consumers to learn about, decide on, and pay for healthcare services in a manner that complements their relationships with healthcare providers. The platform caters to individuals, employer groups, and third-party administrators, positioning itself as a versatile solution in the healthcare ecosystem. With a small team of seven employees, MediXall emphasizes innovation and consumer empowerment in healthcare, striving to streamline the decision-making process for users. As healthcare continues to evolve with digital solutions, MediXall aims to capitalize on this trend by enhancing user experience and expanding its service offerings.
What Products and Services Does MDXL Offer?
- Develops a healthcare marketplace platform to facilitate consumer engagement.
- Offers the Health Karma platform for medical and wellness services.
- Targets individuals, employer groups, and third-party administrators.
- Aims to improve transparency and accessibility in healthcare decisions.
- Provides tools for consumers to learn about, decide on, and pay for healthcare services.
- Focuses on enhancing relationships between consumers and healthcare providers.
How Does MDXL Make Money?
- Generates revenue through service fees associated with transactions on the Health Karma platform.
- Partners with employer groups to provide health benefits and wellness services.
- Offers subscription-based services for third-party administrators.
- Utilizes data analytics to improve service offerings and user experience.
- Focuses on enhancing user engagement to drive repeat usage of the platform.
What Industry Does MDXL Operate In?
The healthcare information services industry is experiencing robust growth, driven by increasing demand for digital healthcare solutions. As consumers seek more control over their healthcare decisions, platforms like MediXall's Health Karma are becoming essential. The market is projected to expand significantly, with a focus on enhancing patient engagement and improving healthcare outcomes. Competitively, MediXall faces challenges from established players but differentiates itself through its unique marketplace approach, targeting both individual consumers and employer groups.
Who Are MDXL's Key Customers?
- Individual consumers seeking medical and wellness services.
- Employer groups looking to provide health benefits to employees.
- Third-party administrators managing health plans.
- Healthcare providers seeking to enhance patient engagement.
- Insurance companies interested in streamlined service offerings.
How MediXall Group, Inc. Is Valued
MediXall Group, Inc. carries a market capitalization of $1.15M, placing it in the micro-cap category. Relative to its peer group, MDXL's quantitative score of 60/100 is roughly in line with the peer average of 58/100.
Company Profile
MediXall Group, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Leesburg, US. The company is led by CEO Travis H. Jackson. MDXL has traded publicly since 2011.
ROE 90%Key Financial Metrics
Return on equity for MediXall Group, Inc. stands at 89.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
MediXall Group, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
MDXL Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that executives believe in its growth potential.
- Community sentiment has shifted positively, with more discussions highlighting the company's innovative approach to healthcare services.
- Recent partnerships have been announced that could enhance MediXall's market presence and service offerings, attracting more users.
- The overall trend in telehealth services is booming, and MediXall is positioned to capitalize on this growing demand.
Bear Case
- Concerns over the company's financial sustainability have been raised, with some analysts questioning its revenue model and profitability.
- Social sentiment remains mixed, with a significant portion of the community expressing skepticism about the company's ability to scale effectively.
- Recent regulatory challenges in the healthcare sector could pose risks to MediXall's operations and future growth.
- Some investors are cautious due to the competitive landscape, where larger players dominate and could overshadow MediXall's efforts.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MDXL Latest News
No recent news available for MDXL.
MDXL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDXL.
Price Targets
Wall Street price target analysis for MDXL.
MDXL MoonshotScore
What does this score mean?
The MoonshotScore rates MDXL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Travis H. Jackson
CEO
Travis H. Jackson has extensive experience in the healthcare sector, having held various leadership roles since the inception of MediXall Group, Inc. He has a strong background in healthcare technology and business development, which has been instrumental in shaping the company’s strategic direction. Jackson holds a degree in Business Administration and has been pivotal in driving MediXall's innovative approach to healthcare solutions.
Track Record: Under Jackson's leadership, MediXall has launched the Health Karma platform, positioning the company as a key player in the healthcare marketplace. His strategic vision has focused on enhancing consumer engagement and expanding the company's service offerings.
MDXL OTC Market Information
The OTC Other tier represents companies that trade on the over-the-counter market but do not meet the stringent requirements of major exchanges like NYSE or NASDAQ. This tier typically includes smaller companies with less liquidity and visibility, which may pose higher risks for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Higher volatility and price fluctuations compared to stocks on major exchanges.
- Limited financial disclosure and transparency, increasing investment risk.
- Potential for lower investor interest and trading volume.
- Verify the company's financial statements and disclosures.
- Assess the management team's experience and track record.
- Investigate the competitive landscape and market positioning.
- Review the company's growth strategy and potential catalysts.
- Consider the liquidity of the stock and trading volume.
- Incorporation and operational history since 1998.
- Established partnerships with employer groups and administrators.
- Active engagement in the healthcare information services sector.
MediXall Group, Inc. Healthcare Stock: Key Questions Answered
What does MediXall Group, Inc. do?
MediXall Group, Inc. operates a healthcare marketplace platform called Health Karma, which facilitates consumer engagement in healthcare decisions. The platform provides access to medical and wellness services, allowing users to learn about, decide on, and pay for healthcare in a transparent manner. Targeting individuals, employer groups, and third-party administrators, MediXall aims to enhance relationships between consumers and healthcare providers.
What are the key growth opportunities for MDXL in healthcare?
MediXall Group, Inc. has several growth opportunities, including expanding its Health Karma platform to integrate telehealth services, which is a rapidly growing market expected to reach $459.8 billion by 2030. Additionally, the company can enhance partnerships with employer groups to increase user acquisition, particularly as employers seek comprehensive health benefits for employees. The rise of consumer-driven healthcare also provides a favorable environment for MediXall to capture a larger market share.
What are the main risks for MDXL?
MediXall Group, Inc. faces several risks, including regulatory changes that could impact the healthcare marketplace and its operational model. The company also contends with high operational costs, which have resulted in a negative profit margin of -1474.8%. Furthermore, intense competition from established players in the healthcare information services sector poses a significant challenge to MediXall's market positioning and growth potential.
What are the key factors to evaluate for MDXL?
MediXall Group, Inc. (MDXL) holds an AI score of 60/100 (moderate). Not financial advice.
How frequently does MDXL data refresh on this page?
MDXL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MDXL's recent stock price performance?
MediXall Group, Inc. (MDXL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative healthcare marketplace platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MDXL overvalued or undervalued right now?
Valuing MediXall Group, Inc. (MDXL) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MDXL?
Before investing in MediXall Group, Inc. (MDXL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial disclosures available due to OTC classification.